Henry Schein, Inc., a leading global provider of healthcare products and services, is headquartered in the United States. Founded in 1932, the company has established a strong presence in the dental, medical, and veterinary sectors, serving healthcare professionals across North America, Europe, and Asia. With a diverse portfolio that includes dental supplies, medical equipment, and practice management software, Henry Schein is renowned for its commitment to innovation and customer service. The company has achieved significant milestones, including its recognition as one of the Fortune 500 and its consistent ranking among the top healthcare distributors globally. Henry Schein's unique approach combines comprehensive product offerings with tailored solutions, making it a trusted partner for healthcare providers seeking to enhance patient care and operational efficiency.
How does Henry Schein's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Henry Schein's score of 85 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Henry Schein, Inc. reported total greenhouse gas emissions of approximately 1,490,993,000 kg CO2e, with emissions distributed across Scope 1 (33,555,000 kg CO2e), Scope 2 (23,287,000 kg CO2e), and a significant portion from Scope 3 (1,490,993,000 kg CO2e). This represents a notable increase from 2023, where total emissions were about 776,259,000 kg CO2e, with Scope 1 emissions at 58,304,000 kg CO2e and Scope 2 at 24,177,000 kg CO2e. Henry Schein has set ambitious climate commitments, aiming to achieve net-zero emissions across all scopes by 2050. The company has established near-term targets to reduce absolute Scope 1 emissions by 42% by 2030 from a 2022 baseline and to increase its sourcing of renewable electricity from 0% in 2022 to 100% by 2030. Additionally, it aims to reduce Scope 3 emissions by 51.6% per million USD value added by 2030 and by 97% by 2050, also from a 2022 baseline. These targets are aligned with the Science-Based Targets initiative (SBTi) and reflect Henry Schein's commitment to sustainable practices within the healthcare sector. The company’s efforts are crucial in addressing climate change and reducing its overall carbon footprint.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 48,846,000 | 00,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 |
Henry Schein's Scope 3 emissions, which increased by 92% last year and increased significantly since 2020, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 74% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Henry Schein has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Henry Schein's sustainability data and climate commitments